Total Payments
$110,420
2020 Payments
$97,568
Companies
1
Transactions
26
Payment Breakdown by Category
Research$78,750 (71.3%)
Consulting$17,350 (15.7%)
Travel$14,234 (12.9%)
Food & Beverage$85.77 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $78,750 | 8 | 71.3% |
| Consulting Fee | $17,350 | 3 | 15.7% |
| Travel and Lodging | $14,234 | 12 | 12.9% |
| Food and Beverage | $85.77 | 3 | 0.1% |
Payments by Type
Research
$78,750
8 transactions
General
$31,670
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Haemonetics Corporation | $110,420 | 26 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $97,568 | 20 | Haemonetics Corporation ($97,568) |
| 2019 | $12,852 | 6 | Haemonetics Corporation ($12,852) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $30,800.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 08/26/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $1,750.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 07/21/2020 | Haemonetics Corporation | Plasma (Device) | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| Category: Devices | ||||||
| 05/04/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $2,800.00 | General |
| Category: Devices | ||||||
| 05/04/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $2,800.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 05/04/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $1,458.74 | General |
| Category: Devices | ||||||
| 04/27/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $21,350.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 04/20/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $13,650.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $2,800.00 | General |
| Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $2,800.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $2,800.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | — | Cash or cash equivalent | $2,800.00 | Research |
| Study: Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System • Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $2,100.00 | General |
| Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $2,100.00 | General |
| Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $568.72 | General |
| Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $446.57 | General |
| Category: Devices | ||||||
| 03/20/2020 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $157.94 | General |
| Category: Devices | ||||||
| 02/10/2020 | Haemonetics Corporation | Plasma (Device) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Devices | ||||||
| 01/27/2020 | Haemonetics Corporation | Plasma (Device) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Devices | ||||||
| 01/27/2020 | Haemonetics Corporation | Plasma (Device) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Devices | ||||||
| 11/19/2019 | Haemonetics Corporation | Plasma (Device) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Devices | ||||||
| 11/19/2019 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $701.40 | General |
| Category: Devices | ||||||
| 07/23/2019 | Haemonetics Corporation | Plasma (Device) | Consulting Fee | Cash or cash equivalent | $8,800.00 | General |
| Category: Devices | ||||||
| 07/23/2019 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | Cash or cash equivalent | $450.49 | General |
| Category: Devices | ||||||
| 04/18/2019 | Haemonetics Corporation | Plasma (Device) | Travel and Lodging | In-kind items and services | $387.84 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Prospective, Randomized, Controlled MultiCenter Clinical Trial to Demonstrate Safety and Effectiveness of the Proposed New Plasma Collection Nomogram Using the NexSys Plasma Collection System | Haemonetics Corporation | $78,750 | 8 |
About Dr. Susan Leitman, M.D
Dr. Susan Leitman, M.D is a Hematology & Oncology healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760924542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Leitman, M.D has received a total of $110,420 in payments from pharmaceutical and medical device companies, with $97,568 received in 2020. These payments were reported across 26 transactions from 1 company. The most common payment nature is "" ($78,750).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bethesda, MD
- Active Since 11/10/2016
- Last Updated 11/10/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1760924542
Products in Payments
- Plasma (Device) $110,420
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bethesda
Sandra Swain, M.d, M.D
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
Dr. Bruce Cheson, Md, MD
Hematology & Oncology — Payments: $665,051
Hematology & Oncology $665,051
Chitra Rajagopal, Md, MD
Hematology & Oncology — Payments: $101,267
Hematology & Oncology $101,267
Phillip Scheinberg, M.d, M.D
Hematology & Oncology — Payments: $80,747
Hematology & Oncology $80,747
Gregory Frykman, M.d, M.D
Hematology & Oncology — Payments: $21,375
Hematology & Oncology $21,375
Dr. James Gulley, Md Phd Facp, MD PHD FACP
Hematology & Oncology — Payments: $11,595
Hematology & Oncology $11,595